Citius Oncology, Inc. (CTOR)

0.7003 +0.03 (+4.37%) USD  |  NASDAQ  |  Oct 21, 16:00
More

Citius Oncology EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CTOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to . Start Trial.
Date Value

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Citius Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade